CME [CME] vs Moody's [MCO] Detailed Stock Comparison

CME Group Inc.

NASDAQ
Loading...

Moody's Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: CME Group Inc. wins in 14 metrics, Moody's Corporation wins in 6 metrics, with 0 ties. CME Group Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric CME Group Inc. Moody's Corporation Better
P/E Ratio (TTM) 24.34 32.74 CME Group Inc.
Price-to-Book Ratio 3.57 26.93 CME Group Inc.
Debt-to-Equity Ratio 12.86 232.68 CME Group Inc.
PEG Ratio 1.03 4.21 CME Group Inc.
EV/EBITDA 21.55 22.70 CME Group Inc.
Profit Margin (TTM) 63.31% 31.69% CME Group Inc.
Operating Margin (TTM) 69.66% 45.74% CME Group Inc.
EBITDA Margin (TTM) 69.66% 45.74% CME Group Inc.
Return on Equity 15.92% 71.36% Moody's Corporation
Return on Assets (TTM) 1.55% 14.82% Moody's Corporation
Free Cash Flow (TTM) $4.19B $2.58B CME Group Inc.
Dividend Yield 4.11% 0.82% CME Group Inc.
1-Year Return 0.01% -5.09% CME Group Inc.
Price-to-Sales Ratio (TTM) 15.36 10.12 Moody's Corporation
Enterprise Value $103.28B $86.58B CME Group Inc.
EV/Revenue Ratio 15.31 11.00 Moody's Corporation
Gross Profit Margin (TTM) N/A 74.46% N/A
Revenue per Share (TTM) $19 $44 Moody's Corporation
Earnings per Share (Diluted) $11.73 $13.93 Moody's Corporation
Beta (Stock Volatility) 0.30 1.45 CME Group Inc.
Short % of Float 1.44% 2.08% CME Group Inc.

CME Group Inc. vs Moody's Corporation Stock Performance Analysis

Loading Price Chart...

CME
MCO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
CME Group Inc.-1.28%5.57%-10.97%-15.22%-2.24%-1.33%
Moody's Corporation1.39%2.32%5.87%4.94%-6.86%-9.00%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
CME Group Inc.0.01%46.40%27.92%186.46%384.94%196.68%
Moody's Corporation-5.09%31.01%28.41%363.18%1,132.05%749.33%

Performance & Financial Health Analysis: CME Group Inc. vs Moody's Corporation

MetricCMEMCO
Market Information
Market Cap i$103.42B$79.66B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i2,489,6541,124,913
90 Day Avg. Volume i2,270,2211,108,261
Last Close$266.08$454.06
52 Week Range$244.56 - $329.16$402.28 - $546.88
% from 52W High-19.16%-16.97%
All-Time High$329.16 (Mar 03, 2026)$546.88 (Jan 15, 2026)
% from All-Time High-19.16%-16.97%
Growth Metrics
Quarterly Revenue Growth0.15%0.08%
Quarterly Earnings Growth0.21%0.06%
Financial Health
Profit Margin (TTM) i0.63%0.32%
Operating Margin (TTM) i0.70%0.46%
Return on Equity (TTM) i0.16%0.71%
Debt to Equity (MRQ) i12.86232.68
Cash & Liquidity
Book Value per Share (MRQ)$80.03$16.93
Cash per Share (MRQ)$7.56$8.54
Operating Cash Flow (TTM) i$4.54B$3.08B
Levered Free Cash Flow (TTM) i$4.11B$2.27B
Dividends
Last 12-Month Dividend Yield i4.11%0.82%
Last 12-Month Dividend i$12.45$3.85

Valuation & Enterprise Metrics Analysis: CME Group Inc. vs Moody's Corporation

MetricCME (Apr 26, 2026)MCO (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i24.3432.74
Forward P/E i22.1424.54
PEG Ratio i1.034.21
Price to Sales (TTM) i15.3610.12
Price to Book (MRQ) i3.5726.93
Market Capitalization
Market Capitalization i$103.42B$79.66B
Enterprise Value i$103.28B$86.58B
Enterprise Value Metrics
Enterprise to Revenue i15.3111.00
Enterprise to EBITDA i21.5522.70
Risk & Other Metrics
Beta i0.301.45
Book Value per Share (MRQ) i$80.03$16.93

Financial Statements Comparison: CME Group Inc. vs Moody's Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCME (2025)MCO (2025)
Revenue/Sales i6.52B7.72B
Cost of Goods Sold i907.00M1.97B
COGS % of Revenue i13.9%25.6%
Gross Profit i5.61B5.75B
Gross Margin i86.1%74.4%
Research & Development iN/AN/A
Operating Income (EBIT) i4.23B3.46B
Operating Margin i64.9%44.9%
EBITDA i98.30M4.06B
EBITDA Margin i1.5%52.6%
Pre-Tax Income i5.33B3.13B
Pre-Tax Income % of Revenue i81.7%40.6%
Income Tax i1.26B668.00M
Income Tax % of Revenue i19.3%8.7%
Net Income (Profit) i4.07B2.46B
Profit Margin i62.5%31.9%

Balance Sheet & Liquidity Metrics

MetricCME (2025)MCO (2025)
Cash & Equivalents i4.42B2.38B
Total Current Assets i165.36BN/A
Total Current Assets % of Revenue i2,536.0%0.0%
Total Current Liabilities i160.30B2.98B
Total Current Liabilities % of Revenue i2,458.3%38.6%
Long-Term Debt i3.42B7.26B
Long-Term Debt % of Revenue i52.5%94.0%
Total Shareholders Equity i28.73B4.21B
Retained Earnings i6.43B17.85B
Retained Earnings % of Revenue i98.7%231.3%
Property, Plant & Equipment i0282.00M

Cash Flow Statement Comparison

MetricCME (2025)MCO (2025)
Operating Cash Flow i4.54B2.97B
Operating Cash Flow % of Revenue i69.6%38.4%
Capital Expenditures i-83.50MN/A
Free Cash Flow i4.19B2.58B
FCF Margin i64.3%33.4%
Debt Repayment i-750.00M-700.00M
Common Stock Repurchase i-266.10M-1.71B

Short Interest & Institutional Ownership Analysis

MetricCMEMCO
Shares Short i4.70M3.18M
Short Ratio i2.282.25
Short % of Float i1.44%2.08%
Shares Outstanding i362.80M174.68M
Float Shares i357.72M163.26M
% Held by Insiders i0.48%13.99%
% Held by Institutions i91.89%79.38%
% Held by Public i7.63%6.63%

Dividend Analysis & Yield Comparison: CME Group Inc. vs Moody's Corporation

MetricCMEMCO
Last 12-Month Dividend i$12.45$3.85
Last 12-Month Dividend Yield i4.11%0.82%
3-Year Avg Annual Dividend i$10.83$3.50
3-Year Avg Dividend Yield i0.92%0.20%
3-Year Total Dividends i$32.50$10.50
Ex-Dividend DateMar 10, 2026Mar 02, 2026